Dose-Response Effects of Short-Term Ashwagandha on Anaerobic Exercise and Cognitive Function in Resistance-Trained Athletes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Ashwagandha (ASH) is an herbal supplement derived from the Withania somnifera plant. It is commonly described as an adaptogen, a substance thought to help the body cope with physical and psychological stress. Previous research has examined ashwagandha supplementation using different doses and supplementation periods. This study examined the effects of seven days of supplementation on muscular strength, exercise performance, cognitive function, and selected physiological measures in healthy, resistance-trained men and women. It also examined whether these effects differed between low and high doses. The study used a crossover design in which each participant completed four conditions: no supplementation, a placebo containing maltodextrin, low-dose ashwagandha at 4 mg per kilogram of body weight per day for seven days, and high-dose ashwagandha at 14 mg per kilogram of body weight per day for seven days. The three supplementation conditions were separated by seven-day washout periods. During the blinded supplementation conditions, neither the participants nor the researchers conducting the assessments knew which supplement was being administered. At the end of each seven-day supplementation period, participants completed laboratory assessments. These included the maximum weight lifted for one repetition on the bench press and leg press, total lifting volume across multiple sets, and the speed and power of bar movement. Participants also completed a 30-second all-out cycling sprint to assess anaerobic power, total work, and fatigue, along with a color-word test to assess cognitive performance. Additional assessments included resting energy expenditure, heart rate, blood pressure, perceived exertion, self-reported readiness, focus, alertness, and selected blood markers related to cholesterol, liver function, and muscle damage.

About this trial record page

What this page shows

Public field values for ClinicalTrials.gov record NCT07853274, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.

What this page does not do

No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.

Where the data comes from

Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.

Last refresh

Last update posted Oct 1, 2026 · Synced Oct 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.